01099.HK
Sinopharm Group Co. Ltd.
HKSE · Healthcare · Medical - Distribution · CN
HKD 15.02
−0.07%Sep 8, 2026, 04:06 UTC
Sinopharm Group and Hansoh Pharmaceutical reached a strategic cooperation agreement, covering broad market, medical access, retail, and DTP special cooperation agreements, upgrading their collaboration to full-chain, full-cycle strategic coordination.
Source:Aug 26, 2026, 03:20 UTC
Sinopharm Holding and AstraZeneca launched a special cooperation project on essential medicines in Shanghai, deepening their strategic partnership in pharmaceutical distribution and grassroots healthcare accessibility.
Source:Aug 25, 2026, 06:22 UTC
Sinopharm Group's stock fell 3.55% to HK$15.75 on August 25, 2026, after Citi lowered its target price to HK$20.4.
Source:Aug 17, 2026, 14:52 UTC
Sinopharm Group's subsidiary China National Accord Medicines reported first-half net profit of 606 million yuan, down 9% year-on-year, with total revenue of 36.266 billion yuan, down 1.4%.
Source: